Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)
Clinical trial NCT05833724 · RECRUITING
Trial details
- NCT number
- NCT05833724
- Sponsor
- Great Novel Therapeutics Biotech & Medicals Corporation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-18
- Primary completion
- 2027-06-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.